Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
aTyr Pharma, Inc. (ATYR) had Return on Investments of -25.95% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-19.53M |
|
-- |
|
-- |
|
$20.31M |
|
$-20.31M |
|
$0.78M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-20.31M |
|
$-20.38M |
|
90.12M |
|
90.12M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$87.49M |
|
$4.53M |
|
$14.04M |
|
$101.53M |
|
$15.53M |
|
$0.60M |
|
$11.35M |
|
$26.88M |
|
$74.66M |
|
$74.66M |
|
$74.66M |
|
92.87M |
|
| Cash Flow Statement Financials | |
$-29.31M |
|
$-1.12M |
|
$36.52M |
|
$14.01M |
|
$20.10M |
|
$6.09M |
|
$2.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.63 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.16% |
|
-26.16% |
|
-19.24% |
|
|
Return on Investments |
-25.95% |
$0.80 |
|
$-0.33 |
|
$-0.33 |
|